ITRM940300A0 - Formulazioni liquide di interferone beta - Google Patents

Formulazioni liquide di interferone beta

Info

Publication number
ITRM940300A0
ITRM940300A0 ITRM940300A ITRM940300A ITRM940300A0 IT RM940300 A0 ITRM940300 A0 IT RM940300A0 IT RM940300 A ITRM940300 A IT RM940300A IT RM940300 A ITRM940300 A IT RM940300A IT RM940300 A0 ITRM940300 A0 IT RM940300A0
Authority
IT
Italy
Prior art keywords
liquid formulations
interferon beta
interferon
beta
formulations
Prior art date
Application number
ITRM940300A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ITRM940300A0 publication Critical patent/ITRM940300A0/it
Priority to ITRM940300A priority Critical patent/IT1272252B/it
Priority to CA002190465A priority patent/CA2190465A1/en
Priority to JP52936095A priority patent/JP3701675B2/ja
Priority to ES95921749T priority patent/ES2148526T3/es
Priority to AT95921749T priority patent/ATE194917T1/de
Priority to AU26704/95A priority patent/AU704827B2/en
Priority to DE69518152T priority patent/DE69518152T2/de
Priority to US08/737,633 priority patent/US6852314B1/en
Priority to DK95921749T priority patent/DK0759775T3/da
Priority to EP95921749A priority patent/EP0759775B1/en
Priority to PT95921749T priority patent/PT759775E/pt
Priority to PCT/EP1995/001825 priority patent/WO1995031213A1/en
Publication of ITRM940300A1 publication Critical patent/ITRM940300A1/it
Application granted granted Critical
Publication of IT1272252B publication Critical patent/IT1272252B/it
Priority to GR20000401996T priority patent/GR3034309T3/el
Priority to US10/892,181 priority patent/US7407651B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
ITRM940300A 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta IT1272252B (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ITRM940300A IT1272252B (it) 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta
DE69518152T DE69518152T2 (de) 1994-05-16 1995-05-15 Flüssige beta-interferon formulierungen
DK95921749T DK0759775T3 (da) 1994-05-16 1995-05-15 Flydende IFN-beta-formuleringer
ES95921749T ES2148526T3 (es) 1994-05-16 1995-05-15 Formulaciones liquidas de ifn-beta.
AT95921749T ATE194917T1 (de) 1994-05-16 1995-05-15 Flüssige beta-interferon formulierungen
AU26704/95A AU704827B2 (en) 1994-05-16 1995-05-15 IFN-beta liquid formulations
CA002190465A CA2190465A1 (en) 1994-05-16 1995-05-15 Ifn-.beta. liquid formulations
US08/737,633 US6852314B1 (en) 1994-05-16 1995-05-15 IFN-β liquid formulations
JP52936095A JP3701675B2 (ja) 1994-05-16 1995-05-15 ＩＦＮ−β液体製剤
EP95921749A EP0759775B1 (en) 1994-05-16 1995-05-15 Ifn-beta liquid formulations
PT95921749T PT759775E (pt) 1994-05-16 1995-05-15 Formulacoes liquidas de ifn-b
PCT/EP1995/001825 WO1995031213A1 (en) 1994-05-16 1995-05-15 IFN-β LIQUID FORMULATIONS
GR20000401996T GR3034309T3 (en) 1994-05-16 2000-08-31 IFN--g(b) LIQUID FORMULATIONS
US10/892,181 US7407651B2 (en) 1994-05-16 2004-07-16 IFN-β liquid formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940300A IT1272252B (it) 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta

Publications (3)

Publication Number Publication Date
ITRM940300A0 true ITRM940300A0 (it) 1994-05-16
ITRM940300A1 ITRM940300A1 (it) 1995-11-16
IT1272252B IT1272252B (it) 1997-06-16

Family

ID=11402534

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940300A IT1272252B (it) 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta

Country Status (13)

Country Link
US (2) US6852314B1 (it)
EP (1) EP0759775B1 (it)
JP (1) JP3701675B2 (it)
AT (1) ATE194917T1 (it)
AU (1) AU704827B2 (it)
CA (1) CA2190465A1 (it)
DE (1) DE69518152T2 (it)
DK (1) DK0759775T3 (it)
ES (1) ES2148526T3 (it)
GR (1) GR3034309T3 (it)
IT (1) IT1272252B (it)
PT (1) PT759775E (it)
WO (1) WO1995031213A1 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
DE69729880T3 (de) * 1996-12-24 2012-05-10 Biogen Idec Ma Inc. Stabile flüssige interferon-zubereitungen
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
PT1224940E (pt) * 1997-09-23 2005-01-31 Rentschler Biotech Gmbh Formulacoes liquidas de intrferao beta
KR19990075253A (ko) * 1998-03-18 1999-10-15 성재갑 약학적으로 안정한 인터페론 제
AU3473999A (en) * 1998-04-03 1999-10-25 Chiron Corporation Injectable igf-formulations containing succinate as buffering agent
WO2002038170A2 (en) * 2000-11-07 2002-05-16 Chiron Corporation Stabilized inteferon compositions
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
US7879320B2 (en) * 2004-05-17 2011-02-01 Ares Trading S.A. Hydrogel interferon formulations
EA010979B1 (ru) 2004-06-01 2008-12-30 Арес Трейдинг С.А. Стабилизированные жидкие препаративные формы интерферона
US7913435B1 (en) * 2005-09-28 2011-03-29 Hummel Iii John F Vehicle display bracket system
WO2009080699A2 (en) * 2007-12-20 2009-07-02 Merck Serono S.A. Peg-interferon-beta formulations
US20120269770A1 (en) * 2010-11-22 2012-10-25 Mark Brader Stable Preserved Compositions of Interferon-Beta
WO2017170626A1 (ja) * 2016-03-30 2017-10-05 千寿製薬株式会社 水性液剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
AU1234383A (en) 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
CA1294215C (en) 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US5183746A (en) 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
IL88233A (en) 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon

Also Published As

Publication number Publication date
WO1995031213A1 (en) 1995-11-23
CA2190465A1 (en) 1995-11-23
AU704827B2 (en) 1999-05-06
DE69518152T2 (de) 2000-12-14
JP3701675B2 (ja) 2005-10-05
IT1272252B (it) 1997-06-16
DK0759775T3 (da) 2000-11-13
JPH10500125A (ja) 1998-01-06
GR3034309T3 (en) 2000-12-29
ES2148526T3 (es) 2000-10-16
US6852314B1 (en) 2005-02-08
AU2670495A (en) 1995-12-05
ATE194917T1 (de) 2000-08-15
EP0759775B1 (en) 2000-07-26
DE69518152D1 (de) 2000-08-31
US7407651B2 (en) 2008-08-05
US20040265270A1 (en) 2004-12-30
ITRM940300A1 (it) 1995-11-16
EP0759775A1 (en) 1997-03-05
PT759775E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69329764D1 (de) Neues kosmetisches präparat
ITRM940300A0 (it) Formulazioni liquide di interferone beta
DE69330180T2 (de) Hyaluronsäure enthaltende formulierungen
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
FI930656A0 (fi) Komposition foer nasal behandling
IT1179015B (it) Gruppo contagocce per l'erogazione di sostanze liquide e pastose come creme di bellezza
ITMI931306A1 (it) Procedimento microbico per la preparazione di mevinolina
ITTO930701A1 (it) Procedimento per il frazionamento di una composizione di grassi
ITMI910774A0 (it) Metodo per la preparazione di interleuchina 6
DE69307502T2 (de) Flüssige pestizide formulierungen
ITRM950861A0 (it) Procedimento per l'assemblaggio di semilavorati per calze-mutanda
ITVE920030A0 (it) Procedimento di sgrassatura di pezzi meccanici ed impianto per effet- tuare il procedimento
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
IT1275802B1 (it) Composizione di interferone
ITMI922181A0 (it) Procedimento per la preparazione di perfluoro-2-metil-4-metossipentano
ITMI910356A1 (it) Ugello di scarico comprendente riduzione di spinta al minimo
KR950701310A (ko) 2-치환된 벤즈알데하이드를 제조하는 방법 및 중간체 화합물(Processes and intermediates for the preparation of 2-substituted benzaldehydes)
ITUD920189A1 (it) Lingottiera perfezionata per la colata continua di bramme sottili
ITMI921783A1 (it) Procedimento per la preparazione di dinitrodifenilmetani
KR960019867U (ko) 의자의 개량구조
ITMI920778A1 (it) Procedimento per la preparazione in discontinuo di alchilaril carbonati
ITBO930005V0 (it) "contenitore-espositore di piatti per vivande"
IT229184Y1 (it) Snodo per poltrona
ITMI911343A0 (it) Composizioni farmaceutiche per il trattamento di dermatosi
ITTV920105A0 (it) Struttura di astina per occhiali

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970514